Description

Eterna Peptides presents premium-grade Gut Inflammation Capsules (2mg), an advanced oral research formulation combining four high-purity synthetic peptides engineered to study gastrointestinal tissue repair, mucosal barrier integrity, and localized anti-inflammatory cascades. Masterfully blending BPC-157, TB-500, KPV, and Larazotide Acetate in an exact 1:1:1:1 mass ratio, this multi-pathway matrix serves as an elite investigative tool for tracking structural enterocyte recovery and cellular tight junction stabilization.

### Advanced 2mg Synergistic Peptide Profile
Each precisely standardized capsule delivers a balanced 2mg active blend composed of:
* **BPC-157 (500mcg):** A stable synthetic pentadecapeptide extensively researched for its gastric mucosal cytoprotective properties, localized angiogenesis promotion via growth factor upregulation, and deep tissue healing kinetics.
* **TB-500 (500mcg):** A low-molecular-weight fragment of Thymosin Beta-4 actively investigated for its capacity to promote actin polymerization, accelerate endothelial cell migration, and support cellular matrix repair.
* **KPV (500mcg):** A naturally occurring tripeptide (Lysine-Proline-Valine) studied within structural immunology for its potent ability to downregulate NF-kB signaling, mitigate pro-inflammatory cytokine expression, and reduce intestinal lumen stress.
* **Larazotide Acetate / AT-1001 (500mcg):** An elite synthetic peptide derivative functioning as a tight junction regulator. Larazotide is heavily utilized in advanced intestinal permeability models to study the inhibition of zonulin, preventing the pathological opening of tight junctions (“leaky gut” modeling).

### Mechanism of Action
The Gut Inflammation matrix operates via distinct, complementary biological pathways to explore mucosal recovery:
* **Tight Junction Stabilization:** Larazotide Acetate acts as a specialized antagonist against zonulin signaling, helping investigate the structural prevention of macromolecular translocation across the intestinal epithelium.
* **Angiogenesis & Tissue Recouping:** BPC-157 and TB-500 synergize to accelerate endothelial cellular migration and new capillary branching, supporting the delivery of systemic substrates required to rebuild eroded mucosal linings.
* **Localized Anti-Inflammatory Signaling:** KPV directly interfaces with cellular inflammatory pathways to mitigate chronic oxidative and cytokine stress, preserving the baseline homeostasis of intestinal epithelial cells.

### Research Applications
In preclinical and in vitro laboratory models, Gut Inflammation Capsules 2mg are utilized to investigate:
* Intestinal permeability dynamics, zonulin-mediated cellular breakdown, and tight junction repair mechanics.
* Accelerated mucosal layer healing, gastric ulcer models, and colitis-induced cellular trauma mitigation.
* Systemic and localized gastrointestinal anti-inflammatory responses and cellular cytokine suppression.
* The comparative baseline bioavailability, absorption kinetics, and stability of multi-peptide oral capsule matrices.

Our capsules are precision-manufactured under strict laboratory quality control guidelines to ensure absolute ingredient standardization, chemical purity, and dependable experimental reproducibility.

—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*